| 标题 |
The efficacy and safety of SYN023 (Zamerovimab and Mazorelvimab injection), the recombinant humanized anti-rabies virus monoclonal antibody mixture, combined with rabies vaccine in a WHO category III rabies post-exposure population: A randomized, double-blind, positive control, phase III clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Vaccine 作者:Xiaoqiang Liu; Jingyu Li; Yang Zha; Z. X. Wang; Ya Jiang; et al 出版日期:2025-06-05 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)